In a recent decision, the Swedish Patent and Market Court provided critical insights into the interpretation of Article 3(b) and 3(d) of the SPC Regulation. The court opined that: The Marketing Authorization (MA) for Trimbow cannot be considered the first MA for the combination of formoterol fumarate and glycopyrronium bromide (Bevespi Aeosphere) because Trimbow contains […]